
Could Nanotechnology Help to End the Fight Against COVID-19? Review of Current Findings, Challenges and Future Perspectives
Author(s) -
Ashagrachew Tewabe Yayehrad,
Ebrahim Abdela Siraj,
Gebremariam Birhanu,
Atlaw Abate Alemie,
Manaye Tamrie Derseh,
Abyou Seyfu Ambaye
Publication year - 2021
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s327334
Subject(s) - pandemic , covid-19 , risk analysis (engineering) , nanotechnology , intensive care medicine , medicine , infectious disease (medical specialty) , business , disease , virology , materials science , pathology , outbreak
A serious viral infectious disease was introduced to the globe by the end of 2019 that was seen primarily from China, but spread worldwide in a few months to be a pandemic. Since then, accurate prevention, early detection, and effective treatment strategies are not yet outlined. There is no approved drug to counter its worldwide transmission. However, integration of nanostructured delivery systems with the current management strategies has promised a pronounced opportunity to tackle the pandemic. This review addressed the various promising nanotechnology-based approaches for the diagnosis, prevention, and treatment of the pandemic. The pharmaceutical, pharmacoeconomic, and regulatory aspects of these systems with currently achieved or predicted beneficial outcomes, challenges, and future perspectives are also highlighted.